Lv5
1400 积分 2024-01-28 加入
Target molecules for future hidradenitis suppurativa treatment
1个月前
已完结
Adalimumab, Ustekinumab, and Secukinumab in the Management of Hidradenitis Suppurativa: A Review of the Real-Life Experience
1个月前
已完结
Real-world safety and clinical response of Janus kinase inhibitor upadacitinib in the treatment of hidradenitis suppurativa: A retrospective cohort study
1个月前
已完结
IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis Suppurativa
1个月前
已完结
Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents
1个月前
已完结
Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa
1个月前
已完结
Janus kinase 1 inhibitor INCB054707 for patients with moderate‐to‐severe hidradenitis suppurativa: results from two phase II studies*
1个月前
已完结
Hidradenitis Suppurativa and JAK Inhibitors: A Review of the Published Literature
1个月前
已完结
Severe herpes simplex virus − 1 Kaposi varicelliform eruption and SARS-CoV-2 infection in atopic dermatitis treated with dupilumab
3个月前
已完结
皖公网安备34019202002308
